Showing results (11-20 of 61) with videos related to

Sort By:
Pageof 7
AIDS Research and Human Retroviruses|December 12, 2012
The design of single-arm clinical trials of combination antiretroviral regimens for treatment-naive HIV-infected patientsLu Zheng, Susan L Rosenkranz, Babafemi Taiwo, et al.
Patient Education and Counseling|October 3, 2000
The practice orientations of physicians and patients: the effect of doctor-patient congruence on satisfactionE Krupat, S L Rosenkranz, C M Yeager, et al.
Diagnostic Microbiology and Infectious Disease|April 29, 2017
Relationship between vancomycin exposure and outcomes among patients with MRSA bloodstream infections with vancomycin Etest® MIC values of 1.5mg/L: A pilot studyD M Martirosov, M R Bidell, M P Pai, et al.
Laboratory Animal Science|October 1, 1985
Retroperitoneal fibromatosis and acquired immunodeficiency syndrome in macaques: epidemiologic studiesC C Tsai, W E Giddens, W R Morton, et al.
Drugs in R&D|September 7, 2017
Boceprevir and Antiretroviral Pharmacokinetic Interactions in HIV/HCV Co-infected Persons: AIDS Clinical Trials Group Study A5309sJennifer J Kiser, Darlene Lu, Susan L Rosenkranz, et al.
Clinical Pharmacology and Therapeutics|May 7, 2003
Effect of simultaneous versus staggered dosing on pharmacokinetic interactions of protease inhibitorsCarla B Washington, Charles Flexner, Lewis B Sheiner, et al.
STAR Protocols|June 27, 2024
Protocols for collecting mouse PDL cells and bone marrow cells, differentiation, and data analysisKridtapat Sirisereephap, Meircurius Dwi Condro Surboyo, Andrea L Rosenkranz, et al.
Biopharmaceutics & Drug Disposition|November 29, 2007
Pharmacokinetic interaction between efavirenz and dual protease inhibitors in healthy volunteersQing Ma, Alan Forrest, Susan L Rosenkranz, et al.
AIDS (London, England)|September 12, 2008
The pharmacokinetics and pharmacogenomics of efavirenz and lopinavir/ritonavir in HIV-infected persons requiring hemodialysisSamir K Gupta, Susan L Rosenkranz, Yoninah S Cramer, et al.
Therapeutic Drug Monitoring|September 21, 2013
Clinical pharmacology quality assurance program: models for longitudinal analysis of antiretroviral proficiency testing for international laboratoriesRobin DiFrancesco, Susan L Rosenkranz, Charlene R Taylor, et al.
Pageof 7